scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1112902259 |
P356 | DOI | 10.1186/S12864-019-5597-1 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12864-019-5597-1 |
P932 | PMC publication ID | 6427842 |
P698 | PubMed publication ID | 30894116 |
P50 | author | Mark G. Sterken | Q55188426 |
Basten Snoek | Q42616823 | ||
P2093 | author name string | Jan E Kammenga | |
Simon C Harvey | |||
Jana J Stastna | |||
Joost A G Riksen | |||
Yiru A Wang | |||
P2860 | cites work | Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease. | Q50511933 |
Genetic variation in strains of zebrafish (Danio rerio) and the implications for ecotoxicology studies. | Q51678940 | ||
No association between 5 new GWAS-linked loci in Parkinson's disease and multiple system atrophy in a Chinese population. | Q52565694 | ||
Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. | Q53290339 | ||
Natural genetic variation in identified genomic loci controlling metabolite levels | Q58776580 | ||
Genetic variation for stress-response hormesis in C. elegans lifespan | Q84185490 | ||
What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases? | Q37389590 | ||
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing | Q37615837 | ||
Natural Genetic Variation in the Caenorhabditis elegans Response to Pseudomonas aeruginosa. | Q37746436 | ||
Genetic modifiers of neurological disease | Q37830879 | ||
Caenorhabditis elegans as a platform for molecular quantitative genetics and the systems biology of natural variation | Q37856452 | ||
Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder | Q37954135 | ||
Worms under stress: C. elegans stress response and its relevance to complex human disease and aging. | Q38083319 | ||
A rapid and massive gene expression shift marking adolescent transition in C. elegans | Q38418687 | ||
A fitness assay for comparing RNAi effects across multiple C. elegans genotypes | Q38918562 | ||
Widespread genetic incompatibility in C. elegans maintained by balancing selection | Q38987657 | ||
Distinct genetic forms of frontotemporal dementia. | Q40059334 | ||
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein | Q40763309 | ||
Ras/MAPK Modifier Loci Revealed by eQTL in Caenorhabditis elegans | Q41383342 | ||
Selection at linked sites shapes heritable phenotypic variation in C. elegans | Q42257621 | ||
Using the mouse to model human disease: increasing validity and reproducibility | Q42599011 | ||
Genotype-dependent lifespan effects in peptone deprived Caenorhabditis elegans | Q42747602 | ||
Genetic screens in Caenorhabditis elegans models for neurodegenerative diseases | Q43416117 | ||
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease | Q46745854 | ||
Temporal dynamics of gene expression in heat-stressed Caenorhabditis elegans. | Q47108673 | ||
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease. | Q48670515 | ||
The genetics of Caenorhabditis elegans | Q24533408 | ||
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models | Q24683059 | ||
Systemic Regulation of RAS/MAPK Signaling by the Serotonin Metabolite 5-HIAA | Q27311127 | ||
Role of pleiotropy in the evolution of a cryptic developmental variation in Caenorhabditis elegans | Q27320539 | ||
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease | Q28244731 | ||
C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging | Q28472271 | ||
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease | Q29614900 | ||
Maintenance of C. elegans | Q29617844 | ||
limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans | Q30488783 | ||
Widespread genomic incompatibilities in Caenorhabditis elegans. | Q30593069 | ||
Contribution of trans regulatory eQTL to cryptic genetic variation in C. elegans. | Q32175942 | ||
Mapping determinants of gene expression plasticity by genetical genomics in C. elegans | Q33267908 | ||
The background puzzle: how identical mutations in the same gene lead to different disease symptoms | Q33365189 | ||
A genome-wide library of CB4856/N2 introgression lines of Caenorhabditis elegans. | Q33471263 | ||
Loss-of-function of β-catenin bar-1 slows development and activates the Wnt pathway in Caenorhabditis elegans | Q33606421 | ||
Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans | Q33729960 | ||
Global genetic robustness of the alternative splicing machinery in Caenorhabditis elegans | Q34131586 | ||
Genome-wide gene expression regulation as a function of genotype and age in C. elegans. | Q34619782 | ||
Natural variation for lifespan and stress response in the nematode Caenorhabditis remanei | Q34711930 | ||
Gene-environment and protein-degradation signatures characterize genomic and phenotypic diversity in wild Caenorhabditis elegans populations | Q34956179 | ||
The epidemiology of dementia associated with Parkinson disease | Q35001358 | ||
Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease | Q35002352 | ||
Natural Genetic Variation Influences Protein Abundances in C. elegans Developmental Signalling Pathways. | Q35960403 | ||
Parkinson's disease dementia: a neural networks perspective | Q36186763 | ||
Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespan | Q36220305 | ||
Genetic variation in laboratory mice | Q36299344 | ||
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model | Q36393015 | ||
Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease | Q36460071 | ||
Natural Genetic Variation Differentially Affects the Proteome and Transcriptome in Caenorhabditis elegans. | Q36876119 | ||
Beyond induced mutants: using worms to study natural variation in genetic pathways. | Q37104190 | ||
Energy crisis precedes global metabolic failure in a novel Caenorhabditis elegans Alzheimer Disease model | Q37274022 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biotechnology | Q7108 |
Caenorhabditis elegans | Q91703 | ||
Synuclein | Q24767155 | ||
P304 | page(s) | 232 | |
P577 | publication date | 2019-03-20 | |
P1433 | published in | BMC Genomics | Q15765854 |
P1476 | title | Genetic background modifies phenotypic and transcriptional responses in a C. elegans model of α-synuclein toxicity | |
P478 | volume | 20 |
Q104286529 | Stressful development: Integrating endoderm development, stress, and longevity |
Q89863572 | Unexpected cell type-dependent effects of autophagy on polyglutamine aggregation revealed by natural genetic variation in C. elegans |
Q92794696 | WormQTL2: an interactive platform for systems genetics in Caenorhabditis elegans |
Search more.